anonymous
Guest
anonymous
Guest
We ALL know now why Merck sold Tildra. Management knows what a dog it is. They are openly saying it, so don't let them tear you down too much as the reps. There is a lot of scrambling and pointing fingers already among leadership. This has the potential to be an epic meltdown!
I think our issues are way bigger than tildra, and that tildra virtually cannot save the company. Opth is a new business but very much unproven. The regular Derm division is dying on the vine.